{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:35:38Z","timestamp":1788561338552,"version":"build-2803163510"},"reference-count":41,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2022,9,2]],"date-time":"2022-09-02T00:00:00Z","timestamp":1662076800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Internal Medicine Journal"],"published-print":{"date-parts":[[2023,5]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Primary aldosteronism (PA) is the most common endocrine cause of hypertension. It is associated with higher cardio\u2010metabolic risk than essential hypertension. Hypertension is common in patients with type 2 diabetes who carry increased cardiovascular risk; however, it is unknown how frequently they are tested for PA.<\/jats:p><\/jats:sec><jats:sec><jats:title>Aim<\/jats:title><jats:p>To assess the extent to which the Endocrine Society's 2016 PA screening guidelines have been applied in a tertiary diabetes care setting and evaluate the demographic, clinical and biochemical characteristics of patients who met screening criteria compared with those who did not.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This is a retrospective cohort study. Data were collected from 272 patients who attended tertiary diabetes clinics and had two or more blood pressure measurements from January to December 2018.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Of 272 patients, 60 (22.1%) had indication(s) for PA screening, but only 14 (23.3%) of 60 were screened using the aldosterone\u2010to\u2010renin ratio (ARR). Five patients who did not meet screening criteria were screened. Only one of 19 patients screened had an abnormal ARR; however, 16 were taking medications known to affect aldosterone and\/or renin production.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>In a tertiary diabetes outpatient setting, only a minority of patients who fulfilled the Endocrine Society criteria for PA screening were actually screened. Appropriate screening for PA in the diabetic hypertensive population is necessary for the diagnosis and targeted treatment of a highly modifiable cardiovascular risk factor. Further studies are needed to develop feasible strategies to identify patients with PA in this population.<\/jats:p><\/jats:sec>","DOI":"10.1111\/imj.15690","type":"journal-article","created":{"date-parts":[[2022,1,9]],"date-time":"2022-01-09T12:10:15Z","timestamp":1641730215000},"page":"709-716","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Screening for primary aldosteronism in the diabetic population: a cohort study"],"prefix":"10.1111","volume":"53","author":[{"given":"Suzanne J.","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Endocrinology Monash Health  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Libianto","sequence":"additional","affiliation":[{"name":"Centre for Endocrinology and Metabolism Hudson Institute of Medical Research  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4620-4976","authenticated-orcid":false,"given":"Jun","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Endocrinology Monash Health  Melbourne Victoria Australia"},{"name":"Department of Medicine Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Wong","sequence":"additional","affiliation":[{"name":"Diabetes and Vascular Medicine Monash Health  Melbourne Victoria Australia"},{"name":"Department of Medicine, School of Clinical Sciences Monash University  Melbourne Victoria Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2022,9,2]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.7326\/M20-0065"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1472"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30319-4"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.120.14765"},{"key":"e_1_2_7_6_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.13922"},{"key":"e_1_2_7_7_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2012-3934"},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2005-1733"},{"key":"e_1_2_7_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/s41371-020-0336-2"},{"key":"e_1_2_7_10_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0000000000001088"},{"key":"e_1_2_7_11_1","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.119.14359"},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.1055\/s-0029-1246189"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-1002"},{"key":"e_1_2_7_14_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.009890"},{"key":"e_1_2_7_15_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc07-0031"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1177\/1479164109350556"},{"key":"e_1_2_7_17_1","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ13-0060"},{"key":"e_1_2_7_18_1","doi-asserted-by":"publisher","DOI":"10.1111\/cen.13370"},{"key":"e_1_2_7_19_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgz293"},{"key":"e_1_2_7_20_1","doi-asserted-by":"publisher","DOI":"10.14740\/jocmr3233w"},{"key":"e_1_2_7_21_1","doi-asserted-by":"publisher","DOI":"10.2337\/diaspect.19.1.25"},{"key":"e_1_2_7_22_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.317.7160.703"},{"key":"e_1_2_7_23_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2015-4061"},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc20-S010"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2017.12.005"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/689360"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgaa177"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.13332"},{"key":"e_1_2_7_29_1","volume-title":"General Practice Management of Type 2 Diabetes: 2016\u201318","author":"The Royal Australian College of General Practitioners","year":"2016"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.1995.tb124634.x"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehz486"},{"key":"e_1_2_7_32_1","unstructured":"International Diabetes FederationRecommendations for Managing Type 2 Diabetes in Primary Care.2017[cited 2021 Aug 20]. Available from URL:www.idf.org\/managing-type2-diabetes"},{"key":"e_1_2_7_33_1","first-page":"S1","article-title":"Diabetes Canada 2018 clinical practice guidelines for the prevention and management of diabetes in Canada","volume":"42","author":"Diabetes Canada Clinical Practice Guidelines Expert Committee","year":"2018","journal-title":"Can J Diabetes"},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.surg.2019.05.087"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-05-18-4587"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.5694\/mja17.00783"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccl.2010.04.001"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2018-00866"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.31128\/AJGP-07-19-4995"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1097\/HJH.0b013e3283656b54"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2017.01.052"},{"key":"e_1_2_7_42_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.02.052"}],"container-title":["Internal Medicine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15690","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/imj.15690","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/imj.15690","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T14:37:31Z","timestamp":1692455851000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/imj.15690"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,2]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["10.1111\/imj.15690"],"URL":"https:\/\/doi.org\/10.1111\/imj.15690","archive":["Portico"],"relation":{},"ISSN":["1444-0903","1445-5994"],"issn-type":[{"value":"1444-0903","type":"print"},{"value":"1445-5994","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,2]]},"assertion":[{"value":"2021-05-15","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-09-02","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}